Sorrento Therapeutics Inc. et al v. Hui Li et al: Second Amended Complaint

Second Amended Complaint in Sorrento Therapeutics Inc., of Delaware, and Levena Suzhou Biopharma Co. Ltd., of China v. Hui Li and Adcentrx Therapeutics Inc., both of California, at the Superior Court of the State of California, County of San Diego.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 366

Date: July 14, 2022

Plaintiffs/Applicants: Sorrento Therapeutics Inc., Levena Suzhou Biopharma Co. Ltd.

Case Number: Xx Xx Xx

Defendants/Respondents: Hui Li, Adcentrx Therapeutics Inc.

Plaintiffs/Applicants Attorneys: Latham & Watkins, Robert Ellison

Topics

Keywords

Adcentrx Therapeutics Hui Li Levena Suzhou Biopharma Sorrento Therapeutics

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.

Sorrento Therapeutics Inc. et al v. Hui Li et al: Second Amended Complaint

You’re only seeing part of this content

Unlimited access for less than $3/day.

Related Content

Topics

Keywords

Related Content

Sorrento Therapeutics Inc. et al v. Hui Li et al: First Amended Complaint

Sorrento Therapeutics Inc. et al v. Hui Li et al: Complaint